Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

Cited In for PubMed (Select 20487147)

1.

Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice.

Hadland SE, Knight JR, Harris SK.

J Dev Behav Pediatr. 2015 Feb-Mar;36(2):115-23. doi: 10.1097/DBP.0000000000000129.

PMID:
25650954
2.

It's not your mother's marijuana: effects on maternal-fetal health and the developing child.

Warner TD, Roussos-Ross D, Behnke M.

Clin Perinatol. 2014 Dec;41(4):877-94. doi: 10.1016/j.clp.2014.08.009. Epub 2014 Sep 27.

PMID:
25459779
3.

Prenatal marijuana exposure predicts marijuana use in young adulthood.

Sonon KE, Richardson GA, Cornelius JR, Kim KH, Day NL.

Neurotoxicol Teratol. 2015 Jan-Feb;47:10-5. doi: 10.1016/j.ntt.2014.11.003. Epub 2014 Nov 13.

PMID:
25446014
4.

Evaluation of Phytocannabinoids from High Potency Cannabis sativa using In Vitro Bioassays to Determine Structure-Activity Relationships for Cannabinoid Receptor 1 and Cannabinoid Receptor 2.

Husni AS, McCurdy CR, Radwan MM, Ahmed SA, Slade D, Ross SA, ElSohly MA, Cutler SJ.

Med Chem Res. 2014 Sep 1;23(9):4295-4300.

PMID:
25419092
5.

Legalizing Cannabis: A physician's primer on the pulmonary effects of marijuana.

Lutchmansingh D, Pawar L, Savici D.

Curr Respir Care Rep. 2014;3(4):200-205. Review.

6.

The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document.

Wilsey B, Atkinson JH, Marcotte TD, Grant I.

Clin J Pain. 2014 Nov 3. [Epub ahead of print]

PMID:
25370134
7.

Re: "trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010".

Hartman RL, Huestis MA.

Am J Epidemiol. 2014 Oct 15;180(8):862-3. doi: 10.1093/aje/kwu251. Epub 2014 Sep 21. No abstract available.

PMID:
25245042
8.

Implications of marijuana legalization for adolescent substance use.

Hopfer C.

Subst Abus. 2014;35(4):331-5. doi: 10.1080/08897077.2014.943386.

PMID:
25127003
9.

Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.

Skosnik PD, Krishnan GP, D'Souza DC, Hetrick WP, O'Donnell BF.

Neuropsychopharmacology. 2014 Dec;39(13):3087-99. doi: 10.1038/npp.2014.166. Epub 2014 Jul 3.

PMID:
24990428
10.

Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Ross EJ, Graham DL, Money KM, Stanwood GD.

Neuropsychopharmacology. 2015 Jan;40(1):61-87. doi: 10.1038/npp.2014.147. Epub 2014 Jun 18.

PMID:
24938210
11.

Youth marijuana use: state of the science for the practicing clinician.

Hadland SE, Harris SK.

Curr Opin Pediatr. 2014 Aug;26(4):420-7. doi: 10.1097/MOP.0000000000000114. Review.

PMID:
24914878
12.

Gone to Pot - A Review of the Association between Cannabis and Psychosis.

Radhakrishnan R, Wilkinson ST, D'Souza DC.

Front Psychiatry. 2014 May 22;5:54. doi: 10.3389/fpsyt.2014.00054. eCollection 2014. Review.

13.

The effects of medical marijuana laws on potency.

Sevigny EL, Pacula RL, Heaton P.

Int J Drug Policy. 2014 Mar;25(2):308-19. doi: 10.1016/j.drugpo.2014.01.003. Epub 2014 Jan 18.

14.

Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile.

Swift W, Wong A, Li KM, Arnold JC, McGregor IS.

PLoS One. 2013 Jul 24;8(7):e70052. doi: 10.1371/journal.pone.0070052. Print 2013.

15.
16.

Neural correlates of performance monitoring in chronic cannabis users and cannabis-naive controls.

Fridberg DJ, Skosnik PD, Hetrick WP, O'Donnell BF.

J Psychopharmacol. 2013 Jun;27(6):515-25. doi: 10.1177/0269881113477745. Epub 2013 Feb 20.

17.

The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis.

Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio M, Pertwee R, Coppola D, Vassallo L, Orlando P, Di Marzo V, Izzo A.

Br J Pharmacol. 2013 May;169(1):213-29. doi: 10.1111/bph.12120.

18.

Development of transcriptomic resources for interrogating the biosynthesis of monoterpene indole alkaloids in medicinal plant species.

Góngora-Castillo E, Childs KL, Fedewa G, Hamilton JP, Liscombe DK, Magallanes-Lundback M, Mandadi KK, Nims E, Runguphan W, Vaillancourt B, Varbanova-Herde M, Dellapenna D, McKnight TD, O'Connor S, Buell CR.

PLoS One. 2012;7(12):e52506. doi: 10.1371/journal.pone.0052506. Epub 2012 Dec 26.

19.

Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA.

Drug Alcohol Depend. 2013 Jun 1;130(1-3):68-76. doi: 10.1016/j.drugalcdep.2012.10.011. Epub 2012 Nov 10.

20.

Individual and contextual predictors of severity of marijuana use events among young frequent users.

Shrier LA, Walls C, Rhoads A, Blood EA.

Addict Behav. 2013 Jan;38(1):1448-56. doi: 10.1016/j.addbeh.2012.05.026. Epub 2012 Aug 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk